New Drugs for the Treatment of Soft Tissue Sarcomas

[1]  I. Christophersen,et al.  Interferon therapy in neoplastic disease. A preliminary report. , 2009, Acta medica Scandinavica.

[2]  L. Baker,et al.  Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer. , 1981, European journal of cancer.

[3]  F. Cavalli,et al.  Phase II study of diamino-dichlorophenyl-methylpyrimidine (DDMP) with folinic acid (CF) protection and rescue. , 1980, European journal of cancer.

[4]  R. Benjamin,et al.  Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia. , 1979, Cancer treatment reports.

[5]  G. Bodey,et al.  Neocarzinostatin: A phase I clinical trial with five‐day intermittent and continuous infusions , 1979, Cancer.

[6]  D. Hammond,et al.  Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors. , 1979, Cancer treatment reports.

[7]  P. Bunn,et al.  Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. , 1979, Cancer treatment reports.

[8]  K. Starling,et al.  ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group study. , 1979, Cancer treatment reports.

[9]  D. Hammond,et al.  Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group. , 1979, Cancer treatment reports.

[10]  J. Ingle,et al.  A phase I study of chlorozotocin (NSC 178248) , 1979, Cancer.

[11]  M. Gosálvez,et al.  Early clinical trial with quelamycin. , 1979, Cancer treatment reports.

[12]  I. Henderson,et al.  Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog. , 1979, Cancer treatment reports.

[13]  H. Ueoka,et al.  Clinical study of aclacinomycin A. , 1979, Cancer treatment reports.

[14]  M. Weil,et al.  Clinical activity of detorubicin: a new anthracycline derivative. , 1979, Cancer treatment reports.

[15]  A. Levine,et al.  Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. , 1979, Cancer research.

[16]  Samson Mk,et al.  Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study. , 1979 .

[17]  H. Biller,et al.  High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer , 1979, Cancer.

[18]  G. Bodey,et al.  Clinical evaluation of peptichemio. , 1979, Cancer treatment reports.

[19]  R. Nitschke,et al.  Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study. , 1979, Cancer treatment reports.

[20]  G. Hahn,et al.  Treatment of superficial human neoplasms by local hyperthermia induced by ultrasound , 1979, Cancer.

[21]  T. Griffin,et al.  Phase I and preliminary phase II study of neocarzinostatin. , 1978, Cancer treatment reports.

[22]  A. Buzdar,et al.  Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma. , 1978, Cancer treatment reports.

[23]  R. Aur,et al.  Phase I study of neocarzinostatin in children with cancer. , 1978, Cancer treatment reports.

[24]  R. Benjamin,et al.  Phase I clinical studies with gallium nitrate. , 1978, Cancer treatment reports.

[25]  R. Livingston,et al.  Phase I clinical evaluation of anguidine. , 1978, Cancer treatment reports.

[26]  R. Benjamin,et al.  Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. , 1978, Cancer research.

[27]  R. Gralla,et al.  Phase II evaluation of pyrazofurin in patients with metastatic sarcoma. , 1978, Cancer treatment reports.

[28]  D. V. Von Hoff,et al.  Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule. , 1978, Cancer treatment reports.

[29]  C. Nogeire,et al.  Phase I study with neocarzinostatin. Tolerance to two hour infusion and continuous infusion , 1978, Cancer.

[30]  A. Brugarolas,et al.  Phase I clinical study of quelamycin. , 1978, Cancer treatment reports.

[31]  A. Mittelman,et al.  Phase I study of N6-benzyladenosine-5'-monophosphate. , 1978, Cancer treatment reports.

[32]  I. Krakoff,et al.  Phase I trial of vindesine in patients with advanced cancer. , 1978, Cancer treatment reports.

[33]  L. Cone,et al.  Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue. , 1978, Cancer treatment reports.

[34]  J. Otten,et al.  Clinical trial of peptichemio in solid tumors of childhood. , 1978, Cancer treatment reports.

[35]  H. Hansen,et al.  Clinical trial of rubidazone in solid tumors and malignant lymphomas. , 1978, Cancer treatment reports.

[36]  E. Wiltshaw,et al.  CHEMOTHERAPY OF SARCOMA A Comparison of Three Regimens , 1978, The Lancet.

[37]  R. Blum,et al.  Maytansine: a phase I study of an ansa macrolide with antitumor activity. , 1978, Cancer treatment reports.

[38]  G. Ramírez,et al.  Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors. , 1978, Cancer treatment reports.

[39]  D. V. Von Hoff,et al.  "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue. , 1978, Cancer treatment reports.

[40]  J. Mirra,et al.  Limb salvage using preoperative intraarterial adriamycin and radiation therapy for extremity soft tissue sarcomas. , 1978, The Australian and New Zealand journal of surgery.

[41]  E. Mindell,et al.  cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. , 1978, Cancer treatment reports.

[42]  K. Hellmann,et al.  Comparison of radiotherapy with and without razoxane (icrf 159) in the treatment of soft tissue sarcomas , 1978, Cancer.

[43]  A. Bartolucci,et al.  Twice weekly 5-azacytidine infusion in dissmeinated metastatic cancer: a phase II study. , 1977, Cancer treatment reports.

[44]  P. Wiernik,et al.  Phase II study of azotomycin in sarcomas. , 1977, Cancer treatment reports.

[45]  N. Hornback,et al.  Preliminary clinical results of combined 433 megahertz microwave therapy and radiation therapy on patients with advanced cancer , 1977, Cancer.

[46]  Perevodchikova Ni,et al.  Phase I clinical study of carminomycin: its activity against soft tissue sarcomas. , 1977 .

[47]  E. Freireich,et al.  A phase I study of pyrazofurin , 1977, Cancer.

[48]  V. Vaitkevicius,et al.  Preliminary experiences with intra-arterial adriamycin. , 1977, Cancer treatment reports.

[49]  C. Coltman,et al.  Phase II trial of Baker's antifol in metastatic sarcoma. , 1977, Cancer treatment reports.

[50]  H. Wallace,et al.  Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children. , 1977, Cancer treatment reports.

[51]  E. W. Hahn,et al.  Local tumor hyperthermia in combination with radiation therapy. 1. Malignant cutaneous lesions , 1977, Cancer.

[52]  G. Bodey,et al.  Phase I-II evaluation of cyclocytidine. , 1977, Cancer treatment reports.

[53]  R. Golbey,et al.  High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis , 1977, Cancer.

[54]  C. Presant,et al.  Amphotericin B plus 1,3‐BIS (2‐chloroethyl)‐1‐nitrosourea (BCNU‐NSC NO. 409962) in advanced cancer. Phase I and preliminary phase II results , 1976, Cancer.

[55]  W. Whitmore,et al.  Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β‐glucuronidase activity , 1976, Cancer.

[56]  R. Izbicki,et al.  Phase I and II evaluation of cytembena in disseminated epithelial ovarian cancers and sarcomas. , 1976, Cancer treatment reports.

[57]  R. Livingston,et al.  Phase i studies with baker's antifol (baf) (nsc 139105) , 1976, Cancer.

[58]  M. Slavik.  Clinical studies with nitrosoureas in various solid tumors. , 1976, Cancer treatment reports.

[59]  G. Zbinden,et al.  Toxicologic screening of daunorubicin (NSC-82151), adriamycin (NSC-123127), and their derivatives in rats. , 1975, Cancer chemotherapy reports.

[60]  R. Livingston,et al.  Hexamethylmelamine--a new drug with activity in solid tumors. , 1973, European journal of cancer.

[61]  G. Ramírez,et al.  Phase II study of azotomycin (NSC-56654). , 1968, Cancer chemotherapy reports.

[62]  R. Gralla,et al.  Phase I trial of chlorozotocin. , 1979, Cancer treatment reports.

[63]  R. Benjamin,et al.  An endomyocardial biopsy study of anthracycline-induced cardiomyopathy - detection, reversibility and potential amelioration , 1979 .

[64]  R. Benjamin,et al.  Survival and relapse patterns of complete responders in adults with advanced soft tissue sarcomas (ASTS) , 1979 .

[65]  N. Saijo,et al.  Effect of ACNU on primary lung cancer, mesothelioma, and metastatic pulmonary tumors. , 1978, Cancer treatment reports.

[66]  W. Rhomberg.  Radiotherapy combined with ICRF 159 (NSC 129943). , 1978, International journal of radiation oncology, biology, physics.

[67]  E. Roley,et al.  Hemangiopericytoma of the uterus: Report of a case with a comprehensive review of the literature , 1978, Journal of surgical oncology.

[68]  J. Ingle,et al.  Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communication. , 1978, Journal of the National Cancer Institute.

[69]  S. Moss,et al.  Phase II study of 5-azacytidine in solid tumors. , 1977, Cancer treatment reports.

[70]  E. Freireich,et al.  Increased remission rate and prolongation of survival in patients with soft tissue sarcomas treated with intensive chemotherapy on a protected environment prophylactic antibiotic program (PEPA) , 1977 .

[71]  E. Borden,et al.  Hexamethylmelamine treatment of sarcomas and lymphomas. , 1977, Medical and pediatric oncology.

[72]  R. Benjamin,et al.  Adriamycin: a new effective agent in the therapy of disseminated sarcomas. , 1975, Medical and pediatric oncology.

[73]  Z. Matějovský.  Effects of Cytembena in the treatment of malignant musculoskeletal tumours. , 1971, Neoplasma.